Related by context. Frequent words. (Click for all words.) 81 Completes Enrollment 80 Drug Candidate 78 FDA Clears 77 Patient Enrollment 77 Presents Positive 77 Clinical Trial Results 77 Phase III Clinical Trial 75 Announces Initiation 75 Receives FDA Clearance 75 FDA Accepts 75 Phase III Trial 75 Initiates Phase 74 Announces Publication 73 Significantly Reduces 73 FDA Approves 72 Receives Patent 72 Preclinical Data 72 Announces Presentation 72 Awarded Patent 72 Pivotal Phase III 72 Announces Positive 71 Pivotal Trial 71 Pivotal Phase 71 Generic Version 71 Shows Promise 71 Combination Therapy 71 COMUNICADO 71 Achieves Milestone 71 Reports Positive 71 Receives Positive 71 Study Demonstrates 70 FDA Clearance 70 Signs Licensing Agreement 70 Low Dose 70 Small Molecule 70 Regains Compliance With 70 Exploit collaboration 70 Explore Strategic Alternatives 70 Completes Tender Offer 70 Inc Therapeutic Competitors 70 CHEAP ONLINE PHARMACY LOW 69 Announces Issuance 69 Reduces Risk 69 Secures Additional 69 J Am Acad 69 Q3 Loss Narrows 69 Monoclonal Antibody 69 Chronic Hepatitis C 69 Regains Compliance 69 Receives CE 69 Metastatic Melanoma 68 Acquires Exclusive 68 Updates Guidance 68 Q1 Loss Narrows 68 Announces Successful Completion 68 Well Tolerated 68 Positive Opinion 68 Provides Guidance 68 Inhibits 68 Announce Collaboration 68 Receives Regulatory 68 Guides FY# Quick Facts 68 PRICE GREAT DISCOUNT FREE 68 ACADIA Pharmaceuticals 68 Extends Tender Offer 68 Q2 Loss Widens 67 J Am Coll 67 CHEAP ONLINE PHARMACY BEST 67 Introduces Next Generation 67 Completes Merger 67 Cholesterol Drug 67 Stockholders Approve Merger 67 Vertex Pharmaceuticals Announces 67 Benign Prostatic Hyperplasia 67 Pulmonary Arterial Hypertension 67 Q2 Loss Narrows 67 Introduces Enhanced 67 Commercialize 67 Files Patent 67 By Phillip Ramati 67 Am J Clin 67 RNAi Therapeutics 67 Bullish Engulfing Pattern 66 MKC# 66 Calls Purchased 66 Develop Next Generation 66 Announces Definitive Agreement 66 Signs Agreements 66 Acquire Assets 66 PHARM 66 TH STAFF WRITER 66 Atopic Dermatitis 66 Patients Treated 66 THE TREND CONTINUES DOWN 66 Successfully Completes 66 Provides Comprehensive 66 Q3 Loss Widens 66 Announces Termination 66 Elderly Patients 66 Blood Thinner 66 NASDAQ CRXL